Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-05 Weiner David B. Director Exercise or conversion +11,667 808,777
2020-03-05 Weiner David B. Director Exercise or conversion · Restricted Stock Unit −11,667 11,666
2020-03-05 Kim Jong Joseph Chief Executive Officer Exercise or conversion +120,100 1,220,807
2020-03-05 Kim Jong Joseph Chief Executive Officer Shares withheld for taxes −37,371 $9.80 $366K 1,183,436
2020-03-05 Kim Jong Joseph Chief Executive Officer Exercise or conversion · Restricted Stock Unit −120,100 120,100
2020-03-05 Humeau Laurent Chief Scientific Officer Exercise or conversion +27,567 77,900
2020-03-05 Humeau Laurent Chief Scientific Officer Shares withheld for taxes −9,857 $9.80 $97K 68,043
2020-03-05 Humeau Laurent Chief Scientific Officer Exercise or conversion · Restricted Stock Unit −27,567 27,566
2020-03-05 KIES PETER CFO Exercise or conversion +27,567 136,697
2020-03-05 KIES PETER CFO Shares withheld for taxes −9,817 $9.80 $96K 126,880
2020-03-05 KIES PETER CFO Exercise or conversion · Restricted Stock Unit −27,567 27,566
2020-01-15 Shepard Jay Director Grant or award · Restricted Stock Unit +12,821 12,821
2020-01-15 Shepard Jay Director Grant or award · Common Stock Option +20,000 20,000
2020-01-13 Kim Jong Joseph Chief Executive Officer Purchase +22,500 $3.11 $70K 1,100,707
2020-01-03 Zoth Lota S. Director Exercise or conversion +4,090 4,090
2020-01-03 Zoth Lota S. Director Exercise or conversion · Restricted Stock Unit −4,090 8,180
2019-12-05 YARNO WENDY L Director Exercise or conversion +4,090 16,350
2019-12-05 YARNO WENDY L Director Exercise or conversion · Restricted Stock Unit −4,090 4,090
2019-08-30 Humeau Laurent Chief Scientific Officer Purchase +4,500 $2.22 $10K 50,333
2019-08-01 Weiner David B. Director Sale −16,352 $2.72 $44K 797,110

Page 33 of 49 · 961 trades